Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness
Paul R. Mittelstadt, João P. Monteiro, Jonathan D. Ashwell
Paul R. Mittelstadt, João P. Monteiro, Jonathan D. Ashwell
View: Text | PDF
Research Article Immunology

Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness

  • Text
  • PDF
Abstract

Generation of a self-tolerant but antigen-responsive T cell repertoire occurs in the thymus. Although glucocorticoids are usually considered immunosuppressive, there is also evidence that they play a positive role in thymocyte selection. To address the question of how endogenous glucocorticoids might influence the adaptive immune response, we generated GRlck-Cre mice, in which the glucocorticoid receptor gene (GR) is deleted in thymocytes prior to selection. These mice were immunocompromised, with reduced polyclonal T cell proliferative responses to alloantigen, defined peptide antigens, and viral infection. This was not due to an intrinsic proliferation defect, because GR-deficient T cells responded normally when the TCR was cross-linked with antibodies or when the T cell repertoire was “fixed” with αβ TCR transgenes. Varying the affinity of self ligands in αβ TCR transgenic mice showed that affinities that would normally lead to thymocyte-positive selection caused negative selection, and alterations in the TCR repertoire of polyclonal T cells were confirmed by analysis of TCR Vβ CDR3 regions. Thus, endogenous glucocorticoids are required for a robust adaptive immune response because of their promotion of the selection of T cells that have sufficient affinity for self, and the absence of thymocyte glucocorticoid signaling results in an immunocompromised state.

Authors

Paul R. Mittelstadt, João P. Monteiro, Jonathan D. Ashwell

×

Figure 3

Reduced antigen-specific T cell frequency in GRlck-Cre T cells.

Options: View larger image (or click on image) Download as PowerPoint
Reduced antigen-specific T cell frequency in GRlck-Cre T cells.
 
(A) GR...
(A) GRlck-Cre T cells proliferate normally to PMA plus ionomycin (P+I) and cross-linked CD3 (anti-CD3/CD28), but not to alloantigen. 5 × 104 (P+I or anti-CD3/CD28) or 1.5 × 105 (alloantigen) purified T cells of the indicated genotypes were cultured in triplicate with 1 μg/ml ionomycin and the indicated amounts of PMA, 1 μg/ml plate-bound anti-CD28 and the indicated amounts of plate-bound anti-CD3, or irradiated B10.A splenocytes in 96-well plates. After 48 (P+I or anti-CD3/CD28) or 72 (alloantigen) hours, wells were pulsed overnight with [3H]thymidine and harvested. Data are shown as the mean cpm of triplicate cultures. Results are representative of 4 (P+I and anti-CD3/CD28) and 3 (alloantigen) independent experiments. (B) WT and GRlck-Cre C57BL/6 mice were immunized with 50 ng OVA in CFA (left panel) or WT and GRlck-Cre B10.A mice were immunized with 10 pmol PCC 81–104 in CFA (right panel). After 8–9 days, T cells from draining lymph nodes were incubated with 5 × 105 irradiated syngeneic splenocytes and the indicated concentrations of antigen for 4 days, pulsed overnight with [3H]thymidine, and harvested. Each point is the average of 3 mice. (C) WT and GRlck-Cre B6 mice were infected with LCMV. At the indicated times after infection, splenic total CD8+ T cells were analyzed. Data are shown as mean ± SEM (day 0, n = 2; day 7, n = 3; day 8, n = 4).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts